Real-World Data Study Finds Breztri Reduces COPD Exacerbation Risk

A real-world data (RWD) study presented at this year’s ATS International Conference shows that Breztri Aerosphere reduces the risk of COPD exacerbations. The study, which looked at RWD from over 2,400 patients, showed that early treatment with the combination therapy reduced the risk of exacerbations by nearly a quarter.

According to Guiliana Grossi, “[Charlie] Strange [MD of the Medical University of South Carolina] emphasized the importance of real-world evidence, explaining it builds upon the existing clinical evidence and demonstrated Breztri’s effectiveness in reducing COPD exacerbation rates while significantly lowering the risk of future exacerbations when used just after worsening symptoms.”

To read more, click here.

(Source: HCP Live, June 14^th, 2023)